RECOVERY Trial

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-105

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

    Pending
  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    University of Oxford
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Older adults (65 and older)

  • Vulnerable Population

    Minority communities unspecified

  • Occupations of Interest

    Unspecified

Abstract

Leading the RECOVERY Clinical Trial for treatments for COVID-19. The UKRI/NIHR funded RECOVERY trial will test if existing or new drugs can help patients hospitalised with confirmed COVID-19. Over 175 hospitals are now involved and >12,000 patients were recruited in just a few weeks with one high-impact publication (https://www.nejm.org/doi/full/10.1056/NEJMoa2021436) and others in review.